HOME >> BIOLOGY >> NEWS
Novel sugar-to-hydrogen technology promises transportation fuel independence

Blacksburg, Va., May 23, 2007 -- The hydrogen economy is not a futuristic concept. The U.S. Department of Energy's 2006 Advance Energy Initiative calls for competitive ethanol from plant sources by 2012 and a good selection of hydrogen-powered fuel cell vehicles by 2020.

Researchers at Virginia Tech, Oak Ridge National Laboratory (ORNL), and the University of Georgia propose using polysaccharides, or sugary carbohydrates, from biomass to directly produce low-cost hydrogen for the new hydrogen economy.

According to the DOE, advances are needed in four areas to make hydrogen fuel an economical reality for transportation production, storage, distribution, and fuel cells. Most industrial hydrogen currently comes from natural gas, which has become expensive. Storing and moving the gas, whatever its source, is costly and cumbersome, and even dangerous. And there is little infrastructure for refueling a vehicle.

"We need a simple way to store and carry hydrogen energy and a simple process to produce hydrogen, said Y.-H. Percival Zhang, assistant professor of biological systems engineering at Virginia Tech.

Using synthetic biology approaches, Zhang and colleagues Barbara R. Evans and Jonathan R. Mielenz of ORNL and Robert C. Hopkins and Michael W.W. Adams of the University of Georgia are using a combination of 13 enzymes never found together in nature to completely convert polysaccharides (C6H10O5) and water into hydrogen when and where that form of energy is needed. This "synthetic enzymatic pathway"research appears in the May 23 issue of PLoS ONE, the online, open-access journal from the Public Library of Science (www.plosone.org).

Polysaccharides like starch and cellulose are used by plants for energy storage and building blocks and are very stable until exposed to enzymes. Just add enzymes to a mixture of starch and water and "the enzymes use the energy in the starch to break up water into only carbon dioxide and
'"/>

Contact: Susan Trulove
STrulove@vt.edu
540-231-5646
Virginia Tech
22-May-2007


Page: 1 2 3 4

Related biology news :

1. Novel system developed to turn data into real-time, interactive 3-D images
2. Novel strategies for healthy aging
3. Novel salamander robot crawls its way up the evolutionary ladder
4. Novel test identifies lymphoma patients likely to respond to new therapy
5. Novel laboratory technique nudges genes into activity
6. Novel approaches to tackling obesity, cancer and MRSA
7. Novel approach to cancer drug given major boost
8. Novel regulation of the common tumor suppressor PTEN
9. Novel EGFR ectodomain mutations in glioblastoma
10. Novel regulatory mechanism identified for key tumor suppressor p53
11. Novel experiment documents evolution of genome in near-real time

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... 2020 , ... Today CJ BIO announced the first in a series of ... taste” phenomenon that is revolutionizing ingredient mixes, nutritional content and flavor profiles across a ... July 13, 2020 at11:00 AM (CDT) during SHIFT20, the virtual edition of the IFT ...
(Date:7/1/2020)... SOMERSET, N.J. (PRWEB) , ... July 01, 2020 ... ... today announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility ... with the company’s existing Japanese clinical supply facility located in Kakegawa, the new ...
(Date:6/25/2020)... MANSFIELD, Mass. (PRWEB) , ... June 24, 2020 ... ... provider of cloud-based enterprise software and software-driven clinical data services that accelerate drug ... trials for low-dose selinexor, an XPO1 inhibitor, in hospitalized patients with severe COVID-19. ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... ... 2020 , ... Regen Suppliers, the one stop shop for ... get the fourth unit free with no limit on the amniotic derived exosomes. ... have been a game changer for regenerative therapies. The products are manufactured at ...
(Date:6/23/2020)... ... June 23, 2020 , ... Nobilis Therapeutics, ... that it has filed an Investigational New Drug application (IND) with the U.S. ... its lead drug candidate NBTX-001 in patients with panic disorder (PD). , "Adding ...
(Date:6/11/2020)... HOUSTON (PRWEB) , ... June 08, 2020 , ... ... first universal vaccine platform delivered through the use of proprietary clean viral vectors, ... vaccine in the United States. Greffex’s platform is the world’s most successful ...
(Date:6/11/2020)... ... June 09, 2020 , ... ... the NEON Micro-Tracer Solution, a highly accurate, contact tracing solution for ... the workplace. Contact tracing, a core disease control measure, is a key strategy ...
Breaking Biology Technology:
Cached News: